| 06/04/2022 |
08:00 to 10:20 |
Plenary |
Prostate
Module – Session on Localized and Intermediate Risk Prostate Cancer |
09:30 to 09:50 |
Race and Prostate Cancer: How Important is it? |
Speaker |
| 06/04/2022 |
08:00 to 10:20 |
Plenary |
Prostate
Module – Session on Localized and Intermediate Risk Prostate Cancer |
09:50 to 09:55 |
Discussion |
Discussant |
| 06/04/2022 |
10:40 to 11:05 |
Plenary |
Prostate
Module – Session on Localized and Intermediate Risk Prostate Cancer |
10:40 to 11:00 |
Radiation Dose /
Hormonal Therapy or Both: Which is most important? |
Speaker |
| 06/04/2022 |
10:40 to 11:05 |
Plenary |
Prostate
Module – Session on Localized and Intermediate Risk Prostate Cancer |
11:00 to 11:05 |
Discussion |
Discussant |
| 06/04/2022 |
11:05 to 12:00 |
Plenary |
Clinical
cases: low and intermediate risk prostate cancer |
|
|
Discussant |
| 06/04/2022 |
15:30 to 17:10 |
Plenary |
Prostate
Module - Session on High Risk and Locally Advanced Prostate Cancer |
15:50 to 16:10 |
The art of
radiotherapy in high risk prostate cancer |
Speaker |
| 06/04/2022 |
15:30 to 17:10 |
Plenary |
Prostate
Module - Session on High Risk and Locally Advanced Prostate Cancer |
16:10 to 16:15 |
Discussion |
Discussant |
| 06/04/2022 |
17:10 to 18:00 |
Plenary |
Clinical
cases: High Risk Prostate Cancer |
|
|
Discussant |
| 07/04/2022 |
08:00 to 09:40 |
Plenary |
Prostate
Module – Session on Recurrent Disease after Local Therapy |
08:00 to 08:25 |
Salvage or
adjuvant post-operative radiotherapy in prostate cancer: where are we in 2022? |
Speaker |
| 07/04/2022 |
08:00 to 09:40 |
Plenary |
Prostate
Module – Session on Recurrent Disease after Local Therapy |
08:25 to 08:30 |
Discussion |
Discussant |
| 07/04/2022 |
10:30 to 11:10 |
Plenary |
Clinical
cases: recurrent prostate cancer |
|
|
Discussant |
